Nao Takano Selected Research

Nao Takano Research Topics

8	Neoplasms (Cancer) 10/2023 - 01/2011
5	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2016
4	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 03/2014
2	Adenocarcinoma 07/2021 - 05/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2016
1	Thrombotic Microangiopathies 10/2023
1	Hemorrhagic Cystitis 10/2023
1	Hyperuricemia 10/2023
1	Tumor Lysis Syndrome 10/2023
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2023
1	Proteinuria 10/2023
1	Neutropenia 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Esophageal Squamous Cell Carcinoma 01/2017
1	Brain Neoplasms (Brain Tumor) 02/2016
1	Hyperemia 01/2011

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2017
2	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2017
2	Bevacizumab (Avastin)FDA Link 12/2020 - 01/2017
2	Gemcitabine FDA Link 05/2019 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 05/2019 - 01/2018
2	XELOXIBA 01/2017 - 12/2016
2	Monoclonal AntibodiesIBA 01/2017 - 12/2016
1	Phosphotransferases (Kinase)IBA 10/2023
1	Pemetrexed (MTA)FDA Link 10/2023
1	Rituximab (Mabthera)FDA Link 10/2023
1	Febuxostat FDA Link 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	CreatinineIBA 10/2023
1	Mesna (Coenzyme M)FDA LinkGeneric 10/2023
1	Immunoglobulin G (IgG)IBA 10/2023
1	SteroidsIBA 10/2023
1	Ifosfamide FDA LinkGeneric 10/2023
1	Fetal Proteins (Fetoprotein)IBA 05/2021
1	acarboxyprothrombin (PIVKA)IBA 05/2021
1	trifluridine tipiracil drug combinationIBA 12/2020
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	Panitumumab (Vectibix)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Contrast MediaIBA 02/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015
1	Vitamin K FDA Link 05/2015
1	Blood Proteins (Serum Proteins)IBA 05/2015
1	CyclinsIBA 05/2015
1	Janus Kinase 2IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 03/2014